Bellco

Working all together to heed the needs of patients, constantly researching the most appropriate therapies

Bellco, with 40 years’ experience, operates worldwide offering therapies and systems for the treatment of renal failure, multiple organ failure, sepsis and congestive heart failure with the goal of providing know-how, reliability and innovation to the scientific and medical communities.

Collaborative Research Club

The FUTURE is NOW

Flexya

FLEXYA™

Simply flexible

FLEXYA™ was born of the experience and innovative technological vision of collaborative research: a versatile, complete and automated instrument designed for chronic patients.

Amplya

AMPLYA™

Simply beyond

AMPLYA™ is a multitherapeutic system for critical care. Integration of multiple extracorporeal treatments - from the more conventional to adsorption treatments - widens the therapeutic opportunities in case of organ failure.

Carpediem

CARPEDIEM™

The Therapeutic System for neonatal patients

CARPEDIEM™ was designed to offer a truly 'paediatric' device: miniature and portable, it responds to the safety and efficacy requirements for renal replacement therapies in neonatal patients.

News & Events

Chronic Line

Chronic Line

The international dialysis population, more and more diversified and elderly, exhibits increasingly critical clinical situations due to complications and comorbidity that progressively compromise the quality of life. The challenges for Bellco’s Therapeutic Dialysis: constant research and innovation for personalised solutions. This objective can be achieved thanks to a complete range of products and systems therapy derived from the combination of advanced engineering and medical and scientific know-how.

Acute Line

Acute Line

Complex clinical conditions, such as those of patients in intensive care, undergoing surgery, with multiple traumas, sepsis, multi-organ failure, cardiopathy, affected by immune pathologies and intoxication, require integrated therapeutic approaches capable of assuring versatility, functionality, rapidity and effectiveness.

Collaborative Research

Collaborative Research

Sharing of technical and scientific skills and experience between Bellco and the most authoritative members of the medical and scientific communities lies at the heart of the continuous research and development of correct therapies.

HEALTH CANADA LICENSES FLEXYA™

Bellco, through Bellco Canada, is glad to announce that FLEXYA™, the next-generation dialysis delivery system designed to deliver hemodialysis and advanced on-line hemodiafiltration therapies...
24
Oct
Keyzonereserved area

top